drugset / Trial / NCT00936962
Evaluation of Meningococcal C Vaccine Programmes in Canadian Children
Phase 4
Completed
452 enrolled
University of British Columbia
Canadian Institutes of Health Research (CIHR) · collab
Non-randomizedSingle-groupOpen-label
Summary
The purpose of the study is to see which of the three current provincial Meningococcal C Conjugate vaccine schedules in Canada provide the longest lasting protection against Meningococcal C disease and to see if a booster vaccination is needed.
Timeline
- Start
- 2009-07
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NeisVac-C | Vaccine | 0.5 ml | Intramuscular |